Scalp application of antioxidants improves scalp condition and reduces hair shedding in a 24-week randomized, double-blind, placebo-controlled clinical trial

被引:15
|
作者
Davis, Michael G. [1 ]
Piliang, Melissa P. [2 ,3 ]
Bergfeld, Wilma F. [2 ,3 ]
Caterino, Tamara L. [1 ]
Fisher, Brian K. [1 ]
Sacha, Jarek P. [1 ]
Carr, Gregory J. [1 ]
Moulton, Laura T. [1 ]
Whittenbarger, Deborah J. [1 ]
Schwartz, James R. [1 ]
机构
[1] Procter & Gamble Co, Mason, OH 45040 USA
[2] Cleveland Clin, Dept Dermatol, Cleveland, OH 44106 USA
[3] Cleveland Clin, Dept Pathol, Cleveland, OH 44106 USA
关键词
antioxidant; hair growth; hair loss; hair shedding; hair treatment; scalp; skin barrier; OXIDATIVE STRESS; ANDROGENETIC ALOPECIA; SEBORRHEIC DERMATITIS; PROTEIN OXIDATION; PYRITHIONE ZINC; DAMAGE; DISORDERS; MINOXIDIL; RADICALS; DANDRUFF;
D O I
10.1111/ics.12734
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Objective Increasing hair fullness is a global unmet need for many men and women. An approach to the problem is to decrease hair fall or shedding by reducing scalp stratum corneum oxidation and barrier damage to increase hair retention. This study evaluated a combination of functional antioxidants and barrier-enhancing cosmetic ingredients to improve scalp condition thereby enabling stronger hair anchorage and longer retention. Methods Male and female subjects with normal scalp condition and self-perceived hair thinning participated in a 24-week, double-blind, placebo-controlled, randomized clinical study assessing either a regimen of treatment shampoo and leave-on treatment containing functional antioxidant and barrier-enhancing agents or an identical placebo chassis shampoo control. The functional ingredients were piroctone olamine, zinc pyrithione, zinc carbonate, niacinamide, panthenol and caffeine. At baseline and after 8, 16 and 24 weeks of product use, several measurements were taken: hair shedding, total hair count (by phototrichogram), hair samples, TEWL and evaluation of biomarkers of scalp and hair conditions. Subjects also completed self-assessment questionnaires. Results Statistically significant effects for functional ingredient-containing treatment regimen versus a placebo control shampoo formulation were observed for reduced hair shedding, increased total hair count, reduced TEWL and improvement in scalp biomarker values. Subjects also noticed these improvements assessed via self-assessment questionnaires. Conclusions These results establish that the use of functional antioxidant and barrier-enhancing agents to further improve scalp condition can enable a reduction in hair shedding and thus an increase in perceived hair fullness. The underlying improvements in scalp condition suggest the hair benefits were achieved as a result of improved scalp skin barrier and scalp condition leading to a viable preventative approach for hair thinning.
引用
收藏
页码:S14 / S25
页数:12
相关论文
共 50 条
  • [41] Once-Daily Treatment With Atomoxetine in Adults With Attention-Deficit/Hyperactivity Disorder: A 24-Week, Randomized, Double-Blind, Placebo-Controlled Trial
    Young, Joel L.
    Sarkis, Elias
    Qiao, Meihua
    Wietecha, Linda
    CLINICAL NEUROPHARMACOLOGY, 2011, 34 (02) : 51 - 60
  • [42] Applicability of Press Needles to a Double-blind Trial A Randomized, Double-blind, Placebo-controlled Trial
    Miyazaki, Shougo
    Hagihara, Akihito
    Kanda, Ryo
    Mukaino, Yoshito
    Nobutomo, Koichi
    CLINICAL JOURNAL OF PAIN, 2009, 25 (05): : 438 - 444
  • [43] Eriobotrya japonica Improves Cognitive Function in Healthy Adolescents: A 12-week, Randomized Double-blind, Placebo-controlled Clinical Trial
    Choi, Eun-Kyung
    Ko, Myoung-Hwan
    Park, Soo-Hyun
    Ha, Ki-Chan
    Baek, Hyang-Im
    Kim, Yong-Jae
    Lee, Joon-Yeol
    Chae, Han-Jung
    Cho, Kyu-Park
    Won, Yu Hui
    Chae, Soo-Wan
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2016, 12 (04) : 370 - 378
  • [44] Gabapentin reduces alcohol consumption and craving: A randomized, double-blind, placebo-controlled trial
    Furieri, Fernando A.
    Nakamura-Palacios, Ester A.
    JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (11) : 1691 - 1700
  • [45] LANREOTIDE REDUCES THE VOLUME OF POLYCYSTIC LIVER: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    van Keimpema, Loes
    Nevens, Frederik
    Vanslembrouck, Ragna
    van Oijen, Martijn G.
    Hoffmann, Aswin L.
    Dekker, Helena M.
    De Man, Robert A.
    Drenth, Joost P.
    HEPATOLOGY, 2009, 50 (04) : 328A - 328A
  • [46] Lanreotide reduces the volume of polycystic liver: A randomized, double-blind, placebo-controlled trial
    Van Keimpema, Loes
    Nevens, Frederik
    Vanslembrouck, Ragna
    Van Oijen, Martijn G. H.
    Hoffmann, Aswin L.
    Dekker, Helena M.
    De Man, Robert A.
    Drenth, Joost P. H.
    GASTROENTEROLOGY, 2009, 137 (05) : 1661 - 1668
  • [47] Rupatadine improves quality of life in mastocytosis: a randomized, double-blind, placebo-controlled trial
    Siebenhaar, F.
    Foertsch, A.
    Krause, K.
    Weller, K.
    Metz, M.
    Magerl, M.
    Martus, P.
    Church, M. K.
    Maurer, M.
    ALLERGY, 2013, 68 (07) : 949 - 952
  • [48] JinqiJiangtang tablets for prediabetes: A randomized, double-blind and placebo-controlled clinical trial
    Wang, Hui
    Guo, Liping
    Shang, Hongcai
    Ren, Ming
    Wang, Xuemei
    Wang, Dehui
    Chen, Jianzong
    Li, Shuanglei
    Chen, Liming
    Wang, Yue
    Liu, Zhi
    Zhai, Jingbo
    Song, Yuzhen
    Cao, Hongbo
    Zhang, Junhua
    Liu, Chunxiang
    Sun, Xiao
    Huo, Da
    Mu, Wei
    Zhang, Li
    Zheng, Wenke
    Yan, Xiaoyan
    Yao, Chen
    SCIENTIFIC REPORTS, 2017, 7
  • [49] CHOLECALCIFEROL SUPPLEMENTATION AND INFLAMMATION: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL
    Seibert, Eric
    Ulrich, Christof
    Trojanowicz, Bogusz
    Lehmann, Ulrike
    Dierkes, Jutta
    Stangl, Gabriele I.
    Girndt, Matthias
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [50] Immunomodulatory Effects of Saffron: A Randomized Double-Blind Placebo-Controlled Clinical Trial
    Kianbakht, S.
    Ghazavi, A.
    PHYTOTHERAPY RESEARCH, 2011, 25 (12) : 1801 - 1805